Notícias

It's a good idea for investors to look outside the U.S. for investment opportunities.

The AI cloud provider's slide has less to do with demand than with what its growth costs.

These energy companies are capitalizing on the surge in AI power demand.

CoreWeave may be looking to reduce risk on memory pricing.

Tesla has pulled back sharply from its December highs, leaving investors to weigh a stock priced for perfection against a wave of catalysts that could rewrite the bull case entirely.

When Meta's CFO admitted the company keeps underestimating its own compute needs, most investors saw a red flag. One analyst saw the opposite, and has been loading up on shares ever since.

Palantir Technologies (NasdaqGS:PLTR) announced a new partnership with Nvidia to deploy sovereign AI solutions for government agencies. The collaboration will use Nvidia's open AI model Nemotron as a core building block within Palantir's software platforms. The partnership focuses on high-security government workloads where data control, compliance, and national sovereignty are central requirements. For investors tracking Palantir Technologies, this move directly targets the government AI...

Analysts are projecting immense growth for the newly public company. Could it mint new millionaires?

Wall Street analysts are highly bullish on Viking Therapeutics, not least because of its promising weight-loss drug, with ongoing and upcoming phase 3 trials.

Micron's top competitor is now trading on a U.S. exchange.

When Amazon raised $25 billion in new debt, most investors saw a red flag. Here is why that reaction got the story exactly backwards.

Yahoo Finance's AI winners and losers include TSMC, Moonshot AI, IBM, and the chip industry.

TSMC expects strong revenue growth, but it's also spending heavily to build new foundry capacity.

A fund's label tells you the category, but the real story is in how the weight is actually distributed among its holdings.

Bears keep recycling the same China narrative about Nvidia, but each earnings report dismantles it faster than they can rebuild it. Here is why the loudest argument against the stock keeps pushing me to buy more.

The integrated energy giant is still an evergreen income investment.

The Dividend King consistently raises its dividend and also pays a high yield.

After a violent June rally sent Rambus shares soaring and a brutal July pullback erased nearly a third of those gains, the memory interface specialist sits at a crossroads between AI-driven growth and mounting bearish signals that insiders may already be acting on.

The Pentagon just earmarked tens of billions for drone dominance, yet the purest military UAV plays have cratered in July, creating the kind of entry window that tends to close fast once appropriations lock in.

The Treasury bond market has historically offered an effective signal right before the onset of a recession.

A covered-call ETF built on small caps instead of Big Tech is dangling a 13% yield, but the tradeoffs hiding behind that number could make or break your portfolio depending on how you hold it.

A portfolio of dividend payers with decade-long track records is outrunning the AI-heavy growth indexes.

Goldman Sachs has never issued a stock split, but its soaring stock price has the Dow off balance.

July has a long history of punishing investors who mistake a good run for a durable business. Three Dividend Kings have kept raising their payouts through every major crash since 1987, and all three just delivered beat-and-raise quarters heading into a summer that already feels shaky.

Apple's frugal AI strategy saved billions while rivals committed to a spending arms race, but new reports reveal a quiet technical crisis that may force the company into an entirely different kind of expensive bet.

But the real goal seemed to be to shut out rival Joby Aviation.

The tech company pre-announced earnings and revenue that fell short of investors' expectations.

Nvidia's self-cooling technology could partially solve a contentious issue.

Elon Musk's companies have significant upside potential but also face substantial risks.

These overlooked consumer staples could reward patient investors with reliable dividends and steady growth.